在社区获得的肺炎中介质蛋白:从生物标志物到精确医学
Xiaoying Zhang1, Tongshuo Zhang2,3, Ruihui Geng1
1Department of Internal Medicine, Hospital of the First Mobile Corps of the Chinese People's Armed Police Force, Dingzhou, Hebei, China.
Frontiers in immunology
|March 12, 2026
概括
社区获得性肺炎 (CAP) 仍然是一个全球威胁. 了解互白素的功能和整合人工智能等先进方法,可以带来精准医学,以更好的CAP管理和结果.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 精准医学是一门精准的医学.
背景情况:
- 社区获得性肺炎 (CAP) 是全球主要的感染死亡原因之一.
- 准确评估CAP严重程度是一个重大的临床挑战.
- 互白蛋白 (ILs) 是炎症的关键调节者,是CAP病理学的核心.
研究的目的:
- 审查CAP中主要互白蛋白的生物和临床特征.
- 讨论多式联运方法,以改善农业政策严重性评估和管理.
- 提出未来的准确医学在农业政策中的方向.
主要方法:
- 基于生理活性 (促炎,抗炎,双作用,新兴) 的互白蛋白的分类.
- 讨论将细胞因子与器官功能障碍参数 (例如MR-proADM) 结合在一起的多模式方法.
- 探索宿主反应模式,以指导抗生素和皮质类固醇治疗.
主要成果:
- 互白蛋白在CAP中扮演着不同的角色,由它们的炎症作用来分类.
- 综合细胞因子和生物标志物的多模式策略显示出严重性评估的前景.
- 主体反应模式为优化CAP治疗提供了洞察力.
结论:
- 对于精确的CAP管理,需要过渡到免疫内型鉴定.
- 整合多学科数据 (遗传学,肺微生物组) 是至关重要的.
- 利用动态患者数据的人工智能 (AI) 模型将使 CAP 中的精准医学成为可能.
更多相关视频
08:16An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
8.0K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
941
相关概念视频
01:30Pneumonia III: Complications and Assessment
1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
01:29Pneumonia II: Pathophysiology
3.8K
The pathophysiology of pneumonia involves the following steps:
3.8K
01:30Pneumonia I: Introduction
1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
01:28Pneumonia IV: Management
992
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
992